The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 5, 2007, Pages 912-916

  Kotsopoulos, Joanne ^a,b   Ghadirian, Parviz ^c   El Sohemy, Ahmed ^b   Lynch, Henry T ^d   Snyder, Carrie ^d   Daly, Mary ^e   Domchek, Susan ^f   Randall, Susan ^g   Karlan, Beth ^h   Zhang, Phil ^a   Zhang, Shiyu ^a   Sun, Ping ^a   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CAFFEINE; CYTOCHROME P450 1A2;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRINKING BEHAVIOR; ENZYME INDUCTION; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; ONCOGENE; PARITY; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CAFFEINE; CANADA; CASE-CONTROL STUDIES; COFFEE; CONFIDENCE INTERVALS; CYTOCHROME P-450 CYP1A2; FEMALE; GENES, BRCA1; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; UNITED STATES;

EID: 34250350720     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-1074     Document Type: Article

References (36)

1. Nkondjock A, Ghadirian P, Kotsopoulos J, et al. Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 2006;118:103-7.
2. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A 1989;86:7696-700.
3. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999;47:445-9.
4. Han XM, Ou-Yang DS, Lu PX, et al. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics 2001;11:429-35.
5. Castorena-Torres F, Mendoza-Cantu A, de Leon MB, et al. CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico. Toxicol Lett 2005;156:331-9.
6. Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005;14:1998-2003.
7. Long JR, Egan KM, Dunning L, et al. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics 2006;16:237-43.
8. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006;295:1135-41.
9. Baker JA, Beehler GP, Sawant AC, Jayaprakash V, McCann SE, Moysich KB. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 2006;136:166-71.
10. Hong CC, Tang BK, Hammond GL, Tritchler D, Yaffe M, Boyd NF. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res 2004;6:R352-65.
11. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-Hydroxyestrone: the 'good' estrogen. J Endocrinol 1996;150 Suppl:S259-65.
12. Jernstrom H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA. Predictors of the plasma ratio of 2-hydroxyestrone to 16α-hydroxyestrone among premenopausal, nulliparous women from four ethnic groups. Carcinogenesis 2003;24:991-1005.
13. Bradlow HL, Jernstrom H, Sepkovic DW, Klug TL, Narod SA. Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16α-hydroxyestrogen metabolites. Mol Genet Metab 2006;87:135-46.
14. Lurie G, Maskarinec G, Kaaks R, Stanczyk FZ, Le Marchand L. Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14:1521-7.
15. Klug TL, Bageman E, Ingvar C, Rose C, Jernstrom H. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels. Mol Genet Metab 2006;89:381-9.
16. Narod SA, Offit K. Prevention and management of hereditary breast cancer. J Clin Oncol 2005;23:1656-63.
17. Devasagayam TP, Kamat JP, Mohan H, Kesavan PC. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1996;1282:63-70.
18. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003;78:728-33.
19. Johnsen NF, Hausner H, Olsen A, et al. Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women. J Nutr 2004;134:2691-7.
20. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
21. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis 1996;17:2279-84.
22. Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
23. Ferrini RL, Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study, Am J Epidemiol 1996;144:642-4.
24. Nagata C, Kabuto M, Shimizu H. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 1998;30:21-4.
25. Vinson JA, Jang J, Yang J, et al. Vitamins and especially flavonoids in common beverages are powerful in vitro antioxidants which enrich lower density lipoproteins and increase their oxidative resistance after ex vivo spiking in human plasma. J Agric Food Chem 1999;47:2502-4.
26. Richelle M, Tavazzi I, Offord E. Comparison of the antioxidant activity of commonly consumed polyphenols beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem 2001;49:3438-42.
27. Bae I, Fan S, Meng Q, et al. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 2004;64:7893-909.
28. Gu L, Gonzalez FJ, Kalow W, Tang BK. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992;2:73-7.
29. Azam S, Hadi N, Khan NU, Hadi SM. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit 2003;9:BR325-30.
30. Gude RP, Menon LG, Rao SG. Effect of caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. J Exp Clin Cancer Res 2001;20:287-92.
31. Hashimoto T, He Z, Ma WY, et al. Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res 2004;64:3344-9.
32. Lu YP, Lou YR, Xie JG, et al. Caffeine and caffeine sodium benzoate have a sunscreen effect, enhance UVB-induced apoptosis, and inhibit UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis 2006;28:199-206.
33. Yang H, Rouse J, Lukes L, et al. Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis 2004;21:719-35.
34. Pozner J, Papatestas AE, Fagerstrom R, et al. Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. Surgery 1986;100:482-8.
35. Landi MT, Sinha R, Lang NP, Kadlubar FF, Human cytochrome P4501A2. IARC Sci Publ: 1999. p. 173-95.
36. Lord RS, Bongiovanni B, Bralley JA, Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev 2002;7:112-29.